NCT05968768 2025-04-10To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)Institute of Mother and Child, Warsaw, PolandPhase 2 Recruiting24 enrolled